Drug
Methionine
Methionine is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
17%
Ph phase_3
1
17%
Ph not_applicable
2
33%
Ph phase_2
2
33%
Phase Distribution
1
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
2(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 31 (16.7%)
N/A2 (33.3%)
Trials by Status
unknown233%
active_not_recruiting117%
completed350%
Recent Activity
1 active trials
Showing 5 of 6
active_not_recruitingphase_2
Methionine PET/CT Studies In Patients With Cancer
NCT00840047
completedphase_1
Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene.
NCT03887169
completednot_applicable
Methionine Tolerance in Healthy Human Adults
NCT02566434
unknownnot_applicable
Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity
NCT03180775
unknownphase_2
Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis
NCT02824419
Clinical Trials (6)
Showing 6 of 6 trials
NCT00840047Phase 2
Methionine PET/CT Studies In Patients With Cancer
NCT03887169Phase 1
Administration of Methionine in Patients With Pulmonary Alveolar Proteinosis by Mutation of the MARS Gene.
NCT02566434Not Applicable
Methionine Tolerance in Healthy Human Adults
NCT03180775Not Applicable
Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity
NCT02824419Phase 2
Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis
NCT00032695Phase 3
Treatment of AIDS Vacuolar Myelopathy With Methionine
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6